Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 21;25(18):4320.
doi: 10.3390/molecules25184320.

The Effects of Flavonoids in Cardiovascular Diseases

Affiliations
Review

The Effects of Flavonoids in Cardiovascular Diseases

Lorena Ciumărnean et al. Molecules. .

Abstract

Flavonoids are metabolites of plants and fungus. Flavonoid research has been paid special attention to in recent times after the observation of their beneficial effects on the cardiovascular system. These favorable effects are exerted by flavonoids mainly due to their antioxidant properties, which result from the ability to decrease the oxidation of low-density lipoproteins, thus improving the lipid profiles. The other positive effect exerted on the cardiovascular system is the ability of flavonoids to produce vasodilation and regulate the apoptotic processes in the endothelium. Researchers suggested that these effects, including their anti-inflammatory function, are consequences of flavonoids' potent antioxidant properties, but recent studies have shown multiple signaling pathways linked to them, thus suggesting that there are more mechanisms involved in the beneficial effect of the flavonoids on the human body. This review aims to present the latest data on the classification of these substances, their main mechanisms of action in the human body, and the beneficial effects on the physiological and pathological status of the cardiovascular system.

Keywords: cardiovascular disease; flavonoids; polyphenols.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Maaliki D., Shaito A., Pintus G., El-Yazbi A.F., Eid A. Flavonoids in hypertension: A brief review of the underlying mechanisms. Curr. Opin. Pharmacol. 2019;45:57–65. doi: 10.1016/j.coph.2019.04.014. - DOI - PubMed
    1. Ball M. Cardiovascular disease. Food Nutr. 2020:576–589. doi: 10.4324/9781003115663-37. - DOI
    1. Curry S.J., Krist A.H., Owens U.K., Barry M.J., Caughey A.B., Davidson K.W., Doubeni C.A., Epling J.W., Kemper A.R., Kubik M., et al. Risk assessment for cardiovascular disease with nontraditional risk factors: Us preventive services task force recommendation statement. JAMA. 2018;320:272–280. doi: 10.1001/jama.2018.8359. - DOI - PubMed
    1. Kumar S., Pandey A. Chemistry and biological activities of flavonoids: An overview. Sci. World J. 2013;2013:1–16. doi: 10.1155/2013/162750. - DOI - PMC - PubMed
    1. Mahomoodally M.F., Gurib-Fakim A., Subratty A.H. Antimicrobial activities and phytochemical profiles of endemic medicinal plants of mauritius. Pharm. Boil. 2005;43:237–242. doi: 10.1080/13880200590928825. - DOI